Fate Pharma Shows FT819 CAR T-Cell Therapy Benefits In Lupus
26 Oct 2025 //
GLOBENEWSWIRE
Fate Therapeutics Receives RMAT Designation from FDA for FT819
14 Apr 2025 //
GLOBENEWSWIRE
Fate Therapeutics First Lupus Patient In FT819 CAR-T Study
09 May 2024 //
GLOBENEWSWIRE
Fate`s FT819 Autoimmune PoC Data At ASGCT Meeting
22 Apr 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support